Fluoxetine depresses glutamate exocytosis in the rat cerebrocortical nerve terminals (synaptosomes) via inhibition of P/Q-type Ca2+ channels

Synapse

Volumn 48, Issue 4, 2003, Pages 170-177

  Wang, Su Jane ^a   Su, Chin Feng ^a   Kuo, Yu Heng ^a  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Antidepressant; Ca2+ channel; Cerebrocortical synaptosomes; Fluoxetine; Glutamate release

Indexed keywords

4 AMINOPYRIDINE; 4BETA PHORBOL DIBUTYRATE; CALCIUM; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; FLUOXETINE; GLUTAMIC ACID; IONOMYCIN; OMEGA AGATOXIN IVA; PROTEIN KINASE C; SUCROSE;

ANIMAL CELL; ARTICLE; BRAIN SYNAPTOSOME; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; DRUG EFFECT; EXOCYTOSIS; MALE; NERVE ENDING; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SIGNAL TRANSDUCTION; SYNAPTIC POTENTIAL;

4-AMINOPYRIDINE; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CALCIUM; CALCIUM CHANNELS, P-TYPE; CALCIUM CHANNELS, Q-TYPE; CEREBRAL CORTEX; EXOCYTOSIS; FLUOXETINE; GLUTAMIC ACID; MALE; MEMBRANE POTENTIALS; NEUROTRANSMITTER AGENTS; POTASSIUM CHANNEL BLOCKERS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS; SYNAPTOSOMES;

EID: 0037448149     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10200     Document Type: Article

References (41)

1. Adler EM, Augustine GJ, Duffy SN, Charlton MP. 1991. Alien intra-cellular calcium chelators attenuate neurotransmitter release at the squid giant synapse. J Neurosci 11:1496-1507.
2. Beasley CM, Masica DN, Potvin JH. 1992. Fluoxetine: a review of receptor and functional effects and their clinical implications. Psychopharmacology (Berl) 107:1-10.
3. Benfield P, Heel RC, Lewis SP. 1986. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32:481-508.
4. Capogna M, Gahwiler BH, Thompson SM. 1996. Presynaptic inhibition of calcium-dependent and -independent release elicited with ionomycin, gadolinium, and alpha-latrotoxin in the hippocampus. J Neurophysiol 75:2017-2028.
5. 2+ channels and their role in neurotransmitter relase. Cell Calcium 24: 709-723.
6. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
7. Choi JS, Hahn SJ, Rhie DJ, Yoon SH, Jo YH, Kim MS. 1999. Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. J Pharmacol Exp Ther 291:1-6.
8. Choi BH, Choi JS, Yoon SH, Rhie DJ, Min DS, Jo YH, Kim MS, Hahn SJ. 2001. Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1. Neuropharmacology 41:443-453.
9. Coffey ET, Sihra TS, Nicholls DG. 1993. Protein kinase C and the regulation of glutamate exocytosis from cerebrocortical synaptosomes. J Biol Chem 268:21060-21065.
10. De Vivo M, Maayani S. 1986. Characterization of the 5-hydroxytryptaminelA receptor-mediated inhibition of forskolin-stimulated adenylyl cyclase activity in guinea pig and rat hippocampual membranes. J Pharmacol Exp Ther 238:248-253.
11. Deak F, Lasztoczi B, Pacher P, Petheo GL, Valeria K, Spat A. 2000. Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells. Neuropharmacology 39:1029-1036.
12. Dunlap K, Luebke JI, Turner TJ. 1995. Exocytotic Ca2+ channels in mammalian central neurons. Trends. Neurosci. 18:89-98.
13. Farrugia G. 1996. Modulation of ionic currents in isolated canine and human jejunal circular smooth muscle cells by fluoxetine. Gastroenterology 110:1438-1445.
14. Grynkiewicz G, Poenie M, Tsien RY. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450.
15. Hahn SJ, Choi JS, Rhie DJ, Oh CS, Jo YH, Kim MS. 1999. Inhibition by fluoxetine of voltage-activated ion channels in rat PC12 cells. Eur. J. Pharmacol. 367:113-118.
16. Hille B. 1994. Modulation of ion-channel function by G-protein-coupled receptors. Trends. Neurosci. 17:531-536.
17. Luebke JI, Dumlap K, Turner TJ. 1993. Multiple calcium channel types control glutamatergic synaptic transmission in the hippocampus. Neuron 11:895-902.
18. Miller RJ. 1998. Presynaptic receptors. Annu Rev Pharmacol Toxicol 38:201-227.
19. Mintz IM, Venema VJ, Swiderek KM, Lee TD, Bean BP, Adams ME. 1992a. P-type calcium channels blocked by the spider toxin omega-Aga-IVA. Nature 355:827-829.
20. Mintz IM, Adams ME, Bean BP. 1992b. P-type calcium channels in rat central and peripheral neurons. Neuron 9:85-95.
21. Mintz IM, Sabatini BL, Regehr WG. 1995. Calcium control of transmitter release at a cerebellar synapse. Neuron 15:675-688.
22. Nicholls DG, Sihra TS. 1986. Synaptosomes possess an exocytotic pool of glutamate. Nature 32:772-773.
23. Pancrazio JJ, Kamatchi GL, Roscoe AK, Lynch C. 1998. Inhibition of neuronal Na+ channels by antidepressant drugs. J. Pharmacol. Exp. Ther. 284:208-214.
24. Plummer MR, Logothetis DE, Hess P. 1989, Elementary properties and pharmacological sensitivities of calcium channels in mammalian peripheral neurons. Neuron 2:1453-1463.
25. Rae JL, Rich A, Zamudio AC, Candia OA. 1995. Effect of Prozac on whole cell ionic currents in lens and corneal epithelia. Am. J. Physiol. 269:C250-C256
26. Rosenmund C, Stevens CF. 1996. Definition of the readily releasable pool of vesicles at hippocampal synapses. Neuron 16:1197-1207.
27. Sanchez-Prieto J, Budd DC, Herrero I, Vazquez E, Nicholls DG. 1996. Presynaptic receptors and the control of glutamate exocytosis. Trends Neurosci 19:235-239.
28. Sihra TS, Nichols RA. 1993. Mechanisms in the regulation of neuro-transmitter release from brain nerve terminals: current hypotheses. Neurochem Res. 18:47-58.
29. Skolnick P. 1999. Antidepressants for the new millennium. Eur J Pharmacol 375:31-40.
30. Skolnick P, Layer RT, Popik P, Nowak G, Paul IA, Trullas R. 1996. Adaptation of NMDA receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry. 29:23-26.
31. Stauderman KA, Gandhi VC, Jones DJ. 1992. Fluoxetine-induced inhibition of synaptosomal [3H]5-HT release: possible Ca(2+)-channel inhibition. Life Sci. 50:2125-2138.
32. Stevens CF, Tsujimoto T. 1995. Estimates for the pool size of releasable quanta at a single central synapse and for the time required to refill the pool. Proc. Natl. Acad. Sci. USA 92:846-849.
33. Tibbs GR, Barrie AP, Van Mieghem FJ, Mcmahon HT, Nicholls DG. 1989. Repetitive action potentials in isolated nerve terminals in the presence of 4-aminopyridine: effects on cytosolic free Ca2+ and glutamate release. J. Neurochem. 53:1693-1699.
34. Turner TJ, Dunlap K. 1995. Pharmacological characterization of pre-synaptic calcium channels using subsecond biochemical measurements of synaptosomal neurosecretion. Neuropharmacology 34:1469-1478.
35. Tytgat J, Maertens C, Daenens P. 1997. Effect of fluoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1). Br. J. Pharmacol. 122:1417-1424.
36. Vazquez E, Sanchez-Prieto J. 1997. Presynaptic modulation of glutamate release targets different calcium channels in rat cerebrocortical nerve terminals. Eur. J. Neurosci. 9:2009-2018.
37. Wiley JL, Cristeollo AF, Balaster RL. 1995. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice. Eur J Pharmacol 294:101-107.
38. Wong DT, Bymaster FP, Englemam EA. 1995. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 57:411-441.
39. Wu LG, Saggau P. 1997. Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci 20:204-212.
40. Yeung SY, Millar JA, Mathie A. 1999. Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine. Br. J. Pharmacol. 128:1609-1615.
41. Zucker RS. 1993. Calcium and transmitter release. J Physiol 87:25-36.